Literature DB >> 23778257

Therapeutic use of stem cells in horses: which type, how, and when?

Lauren V Schnabel1, Lisa A Fortier, C Wayne McIlwraith, Karl M Nobert.   

Abstract

Stem cells are commonly used in equine practice to treat musculoskeletal disorders including tendonitis, osteoarthritis, and more recently laminitis. As the field of regenerative medicine continues to advance, equine practitioners need contemporary information regarding the choice of stem cell type and recommendations regarding clinical implementation of stem cell therapies. Clinicians must also be aware of the limitation in current knowledge regarding stem cells, and the impending regulatory laws that may limit the use of equine stem cells in clinical patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Equine musculoskeletal disorders; FDA; Osteoarthritis; Stem cells; Tendonitis

Mesh：

Year:  2013        PMID： 23778257     DOI： 10.1016/j.tvjl.2013.04.018

Source DB:  PubMed          Journal:  Vet J        ISSN： 1090-0233            Impact factor:   2.688


  20 in total

1.  Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells.

Authors:  Hayley M Lang; Lauren V Schnabel; Jennifer M Cassano; Lisa A Fortier
Journal:  Vet Surg       Date:  2017-03-22       Impact factor: 1.495

2.  Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.

Authors:  Lynn M Pezzanite; Lisa A Fortier; Douglas F Antczak; Jennifer M Cassano; Margaret M Brosnahan; Donald Miller; Lauren V Schnabel
Journal:  Stem Cell Res Ther       Date:  2015-04-12       Impact factor: 6.832

3.  Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.

Authors:  Amir Kol; Joshua A Wood; Danielle D Carrade Holt; Jessica A Gillette; Laurie K Bohannon-Worsley; Sarah M Puchalski; Naomi J Walker; Kaitlin C Clark; Johanna L Watson; Dori L Borjesson
Journal:  Stem Cell Res Ther       Date:  2015-04-15       Impact factor: 6.832

4.  Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells.

Authors:  Marie Maumus; Gautier Roussignol; Karine Toupet; Geraldine Penarier; Isabelle Bentz; Sandrine Teixeira; Didier Oustric; Mireille Jung; Olivier Lepage; Regis Steinberg; Christian Jorgensen; Danièle Noel
Journal:  Front Immunol       Date:  2016-09-27       Impact factor: 7.561

Review 5.  Neuroinflammation, Bone Marrow Stem Cells, and Chronic Pain.

Authors:  Yul Huh; Ru-Rong Ji; Gang Chen
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

6.  Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro.

Authors:  Amanda B Sherman; Brian C Gilger; Alix K Berglund; Lauren V Schnabel
Journal:  Stem Cell Res Ther       Date:  2017-05-25       Impact factor: 6.832

7.  Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.

Authors:  Lauren V Schnabel; Lynn M Pezzanite; Douglas F Antczak; M Julia Bevilaqua Felippe; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2014-01-24       Impact factor: 6.832

8.  Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.

Authors:  N Ardanaz; F J Vázquez; A Romero; A R Remacha; L Barrachina; A Sanz; B Ranera; A Vitoria; J Albareda; M Prades; P Zaragoza; I Martín-Burriel; C Rodellar
Journal:  BMC Vet Res       Date:  2016-03-31       Impact factor: 2.741

9.  Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates.

Authors:  Mattia Quattrocelli; Giorgia Giacomazzi; Sarah Y Broeckx; Liesbeth Ceelen; Selin Bolca; Jan H Spaas; Maurilio Sampaolesi
Journal:  Stem Cell Reports       Date:  2016-01-12       Impact factor: 7.765

10.  Equine Mesenchymal Stromal Cells Retain a Pericyte-Like Phenotype.

Authors:  Cristina L Esteves; Tara A Sheldrake; Lucy Dawson; Timothy Menghini; Burgunde Elisabeth Rink; Karin Amilon; Nusrat Khan; Bruno Péault; Francesc Xavier Donadeu
Journal:  Stem Cells Dev       Date:  2017-05-09       Impact factor: 3.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.